Strattera is a centrally acting sympathomimetic drug whose active ingredient is the chemical compound Atomoxetine. This medicine is used in the treatment of attention deficit hyperactivity disorder is one of the most common neurodevelopmental disorders of childhood. It is usually first diagnosed in childhood and often lasts into adulthood. Children with ADHD may have trouble paying attention, controlling impulsive behaviors (may act without thinking about what the result will be), or be overly active
, a fairly common disorder of behavior and mental development that manifests itself in childhood. This condition appears with symptoms such as difficulty concentrating, hyperactivity (that is, increased motor activity and excitability, one of the signs of an unbalanced nervous system), as well as poorly controlled impulsivity, most often expressed as a lack of control of behavior. Atomoxetine affects the body by inhibiting the reuptake of norepinephrine. In addition to treating the symptom of attention deficit hyperactivity disorder, Strattera is used in the treatment of depression that doesn't respond well to treatment with various categories of antidepressants. Strattera is used in children over 6 years of age and adults.
Most patients note that after taking Strattera, they improve control over emotions, body control, fine motor skills, a feeling of a "clean cold head" comes, talkativeness decreases, an acute desire to satisfy momentary needs for pleasure, composure increases and craving for alcohol, smoking and other bad habits. Additionally, an anti-anxiety and antidepressant effect is manifested.
The manufacturer of the branded Strattera is the pharmaceutical company Lilly del Caribe Inc., based in Puerto Rico, the packer is Lilly S.A. (Spain).
Atomoxetine is the name of the active ingredient for Strattera's commercial patented drug. The patent for Strattera ended in 2017, so today in 2023 you can buy this drug for much less money than before. This is great because many people have been able to afford this drug and improve their cognitive abilities, attention, learning and work efficiency. Especially the drug is important for the normalization of the psychological development of children with attention deficit hyperactivity disorder.
Discounts on drugs used in the treatment of attention deficit hyperactivity disorder are not as common as, say, discounts on cough medicines or for the treatment of erectile dysfunction. However, quite often Atomoxetine falls under various promotions that apply to antidepressants and anti-anxiety drugs. So if you're looking for some great deals on Strattera, look no further than the specific ADHD drug section, but the antidepressant section. You are most likely to find profitable coupons or discounts for purchasing a large number of capsules in one order. Always carefully check the dosage of the medicine and purchase only the one that corresponds to the one prescribed by your doctor.
There is a convenient and real way to save money when buying Strattera: order a generic drug in one of the many large Indian online pharmacies or in international pharmacies that stock Indian medicines. Most generics are made in India. In addition, the products of this particular country are of the highest quality.
With the cost of branded Strattera in form of oral capsules with dosage of 10 mg being around $440 for a supply of 30 capsules, few people could afford this medicine, especially considering that it must be used on a regular basis for a very long time, optimally - constantly. Prices for other dosages (18.25, 40 and 60 mg) are even higher. Generic Strattera is at least four times cheaper than the original drug, and in some cases you can save even more. However, even when buying an original medicine online, the end consumer can get it at a price 20% lower than in offline pharmacies. This is due to the fact that online pharmacies don't bear the cost of maintaining large retail space and the salaries of pharmacists.
The action of Strattera generics is completely similar to the action of a branded drug, since they contain the same active ingredient in similar dosages. Moreover, it happens that patients note: generics are better tolerated by the body and provoke not as strong side effects as the original medicine. All the problems of Strattera generics are exactly the same as those of the branded drug, and are mainly side effects or individual insensitivity to the drug.
Although Strattera is one of the most effective drugs for the treatment of attention deficit hyperactivity disorder, it cannot be denied that it causes a considerable number of side effects. Among them are abdominal pain, loss of appetite, constipation, vomiting, nausea, palpitations. Drowsiness is very common, dilated pupils, rash, flu-like symptoms, dry mouth are sometimes observed. Separately, it is worth noting side effects from the urinary and reproductive system. These are dysuria, difficulty urinating, dysmenorrhea, impaired ejaculation or its absence, impaired orgasm or spontaneous ejaculation, decreased libido. As a rule, these side effects subside after 2-4 weeks of taking the drug and don't require its withdrawal. However, in order to avoid interruption of treatment, it is desirable to be aware of possible discomfort in advance. Some patients are advised to take the medicine after meals to avoid severe nausea.
Strattera and its generics are available as 10, 18, 25, 40, and 60 mg capsules. The content of the capsule is a white or almost white powder, which is irritating to the eyes, so opening the capsule should be avoided.
For children and adolescents weighing up to 70 kg, the recommended initial daily dose is approximately 500 mcg/kg and is increased to a therapeutic daily dose of approximately 1.2 mg/kg no earlier than 3 days later. The total daily dose may be increased to a maximum dose of 1.8 mg/kg not earlier than 2-4 weeks after the start of the drug.
The recommended maintenance dose is approximately 1.2 mg/kg/day. The recommended maximum daily dose is 1.8 mg/kg or 120 mg.
In children and adolescents weighing up to 70 kg, the safety of single doses and total daily doses exceeding 1.8 mg/kg has not been systematically evaluated.
For children and adolescents weighing more than 70 kg, as well as adults, the recommended initial daily dose is 40 mg and is increased to a therapeutic daily dose of about 80 mg no earlier than 3 days after the start of treatment. If there is no improvement in the patient's condition, the total daily dose may be increased to a maximum dose of 120 mg no earlier than 2-4 weeks after the start of the therapy.
The recommended maintenance dose is 80 mg and the maximum daily dose is 120 mg.
In the event of adverse events when taking the drug once day, patients can be recommended to take the drug two times a day, with the dose divided into morning intake and intake in the late afternoon or early evening.